These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8237994)

  • 1. Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip.
    Van Veldhuizen PJ; Neff J; Murphey MD; Bodensteiner D; Skikne BS
    Am J Hematol; 1993 Dec; 44(4):243-8. PubMed ID: 8237994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
    Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A
    Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
    Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anomalies of coagulation and fibrinolytic activity in patients with chronic pulmonary thromboembolism].
    Aiello E; Presbitero P; Stella S; Borchiellini A; Garis G; Bazzan M; Schinco P; Tamponi G
    G Ital Cardiol; 1993 Apr; 23(4):345-51. PubMed ID: 8319862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
    Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
    Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation.
    Bellart J; Gilabert R; Fontcuberta J; Carreras E; Miralles RM; Cabero L
    Am J Perinatol; 1998 Feb; 15(2):81-5. PubMed ID: 9514130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue plasminogen activator (t-PA) activity in patients with Noonan syndrome.
    Mehta P; Parker RI
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):532-6. PubMed ID: 20686427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism.
    Chadarevian R; Bruckert E; Leenhardt L; Giral P; Ankri A; Turpin G
    J Clin Endocrinol Metab; 2001 Feb; 86(2):732-7. PubMed ID: 11158038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
    Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology.
    Gris JC; Neveu S; Mares P; Biron C; Hedon B; Schved JF
    J Lab Clin Med; 1993 Nov; 122(5):606-15. PubMed ID: 8228580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolytic imbalance in essential thrombocythemia: role of platelets.
    Bazzan M; Tamponi G; Gallo E; Stella S; Schinco PC; Pannocchia A; Pileri A
    Haemostasis; 1993; 23(1):38-44. PubMed ID: 8477907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis?
    Glueck CJ; Glueck HI; Mieczkowski L; Tracy T; Speirs J; Stroop D
    Thromb Haemost; 1993 May; 69(5):460-5. PubMed ID: 8322268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoprotein(a), and therapy with Stanozolol.
    Glueck CJ; Freiberg R; Glueck HI; Tracy T; Stroop D; Wang Y
    Am J Hematol; 1995 Apr; 48(4):213-20. PubMed ID: 7717367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation inhibitors and fibrinolytic parameters in patients on peritoneal dialysis and haemodialysis.
    Alwakeel J; Gader AM; Hurieb S; al-Momen AK; Mitwalli A; Abu Aisha H
    Int Urol Nephrol; 1996; 28(2):255-61. PubMed ID: 8836799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofibrinolysis: a common, major cause of osteonecrosis.
    Glueck CJ; Freiberg R; Glueck HI; Henderson C; Welch M; Tracy T; Stroop D; Hamer T; Sosa F; Levy M
    Am J Hematol; 1994 Feb; 45(2):156-66. PubMed ID: 8141121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
    Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
    Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombosis after hip replacement. Relationship to the fibrinolytic system.
    Eriksson BI; Eriksson E; Gyzander E; Teger-Nilsson AC; Risberg B
    Acta Orthop Scand; 1989 Apr; 60(2):159-63. PubMed ID: 2471386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolytic Dysregulation in Total Joint Arthroplasty Patients: Potential Clinical Implications.
    Guler N; Burleson A; Syed D; Banos A; Hopkinson W; Hoppensteadt D; Rees H; Fareed J
    Clin Appl Thromb Hemost; 2016 May; 22(4):372-6. PubMed ID: 26207021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke.
    Johansson L; Jansson JH; Boman K; Nilsson TK; Stegmayr B; Hallmans G
    Stroke; 2000 Jan; 31(1):26-32. PubMed ID: 10625711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.